Patent · US Active

Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease

US9610247B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignee

Torrent Pharmaceuticals Limited · IN

Inventors

Chaitanya Dutt · Gandhinagar, IN
Vijay Chauthaiwale · Gandhinagar, IN
Ram Gupta · Lucknow, IN
Shitalkumar Zambad · Sayla, IN
Shailesh Deshpande · Gandhinagar, IN
Jignesh Kotecha · Gandhinagar, IN
Ramesh Gupta · Prospect, US
Sanjay Srivastava · Gandhinagar, IN
Laxmikant Chhipa · Mahesana, IN
Jaya Abraham · Gandhinagar, IN

Key dates

Filing date	May 12, 2014
Grant date	Apr 4, 2017
Priority date	—
Expiry date	May 12, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Present invention relates to a low dose pharmaceutical composition, preferably oral composition comprising therapeutically effective amount of [(2-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H,5H-10-thia-1,4a-diaza-benzo[a]azulene-3-carbonyl)-amino]-acetic acid (compound A) in the range of 2.5 mg to 60 mg. Present invention also relates to a method of treating inflammatory bowel disease in a mammal by administrating said low dose pharmaceutical composition. Further, present invention relates to a use of the compound A for the preparation of low dose pharmaceutical composition for the treatment of inflammatory bowel disease in a mammal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.